Background: Preoperative breast magnetic resonance imaging (mri) is commonly requested by surgeons in the initial workup of women with breast cancer; however, its use is controversial. We performed a survey of breast cancer surgeons across Canada to investigate current knowledge about, attitudes to, and self-reported use of preoperative breast mri in a publicly funded health care system in light of the limited evidence to support it. Methods: All identified general surgeons in Canada were mailed a survey instrument designed to probe current practice and knowledge of published trials. Results: Of 403 responding surgeons, 233 (58%) indicated that they performed breast cancer surgery. Of those 233, 218 (94%) had access to breast mri and completed the entire survey. Overall, 54.6% of responding surgeons felt that breast mri was useful in surgical planning, and more than half (58.3%) indicated that their frequency of use was likely to increase over the next 5 years. Surgeons found preoperative mri most useful in detecting mammographically occult disease (71.5% of respondents) and in planning for breast-conserving surgery (57.3%). The main limitations reported were timely access to mri (51%) and false positives (36.7%). Responses suggest a knowledge gap in awareness of published trials in breast mri. Conclusions: Our study found that, in early-stage breast cancer, self-reported use of mri by breast cancer surgeons in Canada varied widely. Reported indications did not align with published data, and significant gaps in self-reported knowledge of the data were evident. Our results would support the development and dissemination of guidelines to optimize use of mri.
Background: Preoperative breast magnetic resonance imaging (mri) is commonly requested by surgeons in the initial workup of women with breast cancer; however, its use is controversial. We performed a survey of breast cancer surgeons across Canada to investigate current knowledge about, attitudes to, and self-reported use of preoperative breast mri in a publicly funded health care system in light of the limited evidence to support it. Methods: All identified general surgeons in Canada were mailed a survey instrument designed to probe current practice and knowledge of published trials. Results: Of 403 responding surgeons, 233 (58%) indicated that they performed breast cancer surgery. Of those 233, 218 (94%) had access to breast mri and completed the entire survey. Overall, 54.6% of responding surgeons felt that breast mri was useful in surgical planning, and more than half (58.3%) indicated that their frequency of use was likely to increase over the next 5 years. Surgeons found preoperative mri most useful in detecting mammographically occult disease (71.5% of respondents) and in planning for breast-conserving surgery (57.3%). The main limitations reported were timely access to mri (51%) and false positives (36.7%). Responses suggest a knowledge gap in awareness of published trials in breast mri. Conclusions: Our study found that, in early-stage breast cancer, self-reported use of mri by breast cancer surgeons in Canada varied widely. Reported indications did not align with published data, and significant gaps in self-reported knowledge of the data were evident. Our results would support the development and dissemination of guidelines to optimize use of mri.
Entities:
Keywords:
Preoperative assessment; breast cancer; magnetic resonance imaging
Authors: H Preibsch; G Blumenstock; E Oberlechner; S Y Brucker; M Hahn; A Staebler; B Wiesinger; C D Claussen; K Nikolaou; K C Siegmann-Luz Journal: Eur J Radiol Date: 2017-07-01 Impact factor: 3.528
Authors: Neha Vapiwala; Wei-Ting Hwang; Carolyn J Kushner; Mitchell D Schnall; Gary M Freedman; Lawrence J Solin Journal: Cancer Date: 2016-12-16 Impact factor: 6.860
Authors: Floor M Knuttel; Gisela L G Menezes; Maurice A A J van den Bosch; Kenneth G A Gilhuijs; Nicky H G M Peters Journal: J Surg Oncol Date: 2014-05-26 Impact factor: 3.454
Authors: Lindsay Turnbull; Sarah Brown; Ian Harvey; Catherine Olivier; Phil Drew; Vicky Napp; Andrew Hanby; Julia Brown Journal: Lancet Date: 2010-02-13 Impact factor: 79.321
Authors: R M Mann; C E Loo; T Wobbes; P Bult; J O Barentsz; K G A Gilhuijs; C Boetes Journal: Breast Cancer Res Treat Date: 2010-01 Impact factor: 4.872
Authors: Alessandro Fancellu; Valeria Sanna; Pietrina Cottu; Cladio F Feo; Antonio M Scanu; Giulia Farina; Antonio Bulla; Angela Spanu; Panagiotis Paliogiannis; Alberto Porcu Journal: Breast Date: 2018-03-07 Impact factor: 4.380
Authors: Elissa M Ozanne; Julie E Weiss; Tracy Onega; Wendy DeMartini; Karla Kerlikowske; Diana S M Buist; Louise Henderson; Rebecca A Hubbard; Martha Goodrich; Anna N A Tosteson; Beth A Virnig; Cristina O'Donoghue Journal: Am J Surg Date: 2016-06-12 Impact factor: 2.565
Authors: Xiao Xu; Pamela R Soulos; Jeph Herrin; Shi-Yi Wang; Craig Evan Pollack; Brigid K Killelea; Howard P Forman; Cary P Gross Journal: PLoS One Date: 2022-03-15 Impact factor: 3.240